jornwaterlander

jornwaterlander

Novo Nordisk stock has lost quite some weight since the release of Eli lilly's drug Zepbound and Mounjaro and since the rise of compounded, or generic copycat GLP-1 alternatives. The growth of the company has slown down a bit, but the overall GLP-1 market growth is still impressive and misunderstood. Both Lilly and NVO have become some of the cheapest PEG stocks...

jornwaterlander

ASML is the monopoly Extreme ultra violet machinery company. There is no one close to it's technology or there is no one investing enough to R&D a thing like it. The whole AI datacenter and cloud chip growth depends on EUV machinery of ASML developed in 2013 (>10y of PhD level R&D deveopment). The first new High-NA EUV systems have been deployed at Intel in July...

jornwaterlander

ASML is the monopoly Extreme ultra violet machinery company. There is no one close to it's technology or there is no one investing enough to R&D a thing like it. The whole AI datacenter and cloud chip growth depends on EUV machinery of ASML developed in 2013 (>10y of PhD level R&D deveopment). The first new High-NA EUV systems have been deployed at Intel in July...